3D-QSAR illusions

被引:102
作者
Doweyko, AM [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, CADD, Dept Macromol Struct, Princeton, NJ 08543 USA
关键词
CoMFA; HASL; QSAR;
D O I
10.1007/s10822-004-4068-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3D-QSAR is typically used to construct models (1) to predict activities, (2) to illustrate significant regions, and (3) to provide insight into possible interactions. To the contrary, examples are described herein which make it clear that the predictivity of such models remains elusive, that so-called significant regions are subject to the vagaries of alignment, and that the nature of possible interactions heavily depends on the eye of the beholder. Although great strides have been made in the imaginative use of 3D-descriptors, 3D-QSAR remains largely a retrospective analytical tool. The arbitrary nature of both the alignment paradigm and atom description lends itself to capricious models, which in turn can lead to distorted conclusions. Despite these illusionary pitfalls, predictions can be enhanced when the test set is bounded by the descriptor space represented in the training set. Interpretation of significant interaction regions becomes more meaningful when alignment is constrained by a binding site. Correlations obtained with a variety of atom descriptors suggest choosing useful ones, in particular, in guiding synthetic effort.
引用
收藏
页码:587 / 596
页数:10
相关论文
共 54 条
[1]   Four-dimensional quantitative structure-activity relationship analysis of a series of interphenylene 7-oxabicycloheptane oxazole thromboxane A2 receptor antagonists [J].
Albuquerque, MG ;
Hopfinger, AJ ;
Barreiro, EJ ;
de Alencastro, RB .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (05) :925-938
[2]   Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies [J].
Avery, MA ;
Alvim-Gaston, M ;
Rodrigues, CR ;
Barreiro, EJ ;
Cohen, FE ;
Sabnis, YA ;
Woolfrey, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :292-303
[3]   3D-QSAR CoMFA study on imidazolinergic I2 ligands:: A significant model through a combined exploration of structural diversity and methodology [J].
Baurin, N ;
Vangrevelinghe, E ;
Morin-Allory, L ;
Mérour, JY ;
Renard, P ;
Payard, M ;
Guillaumet, G ;
Marot, C .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (06) :1109-1122
[4]   A 3D QSAR study on a set of dopamine D4 receptor antagonists [J].
Boström, J ;
Böhm, M ;
Gundertofte, K ;
Klebe, G .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (03) :1020-1027
[5]   CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: Exploration of a binding mode at the active site [J].
Buolamwini, JK ;
Assefa, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :841-852
[6]   SYNTHESIS, LIGAND-BINDING, AND QSAR (COMFA AND CLASSICAL) STUDY OF 3-BETA-(3'-SUBSTITUTED PHENYL), 3-BETA-(4'-SUBSTITUTED PHENYL), AND 3-BETA-(3',4'-DISUBSTITUTED PHENYL)TROPANE-2-BETA-CARBOXYLIC ACID METHYL-ESTERS [J].
CARROLL, FI ;
MASCARELLA, SW ;
KUZEMKO, MA ;
GAO, YG ;
ABRAHAM, P ;
LEWIN, AH ;
BOJA, JW ;
KUHAR, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (18) :2865-2873
[7]   3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors [J].
Chakraborti, AK ;
Gopalakrishnan, B ;
Sobhia, ME ;
Malde, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) :1403-1408
[8]  
Cramer III., 1991, United State Patent, Patent No. 5025388
[9]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[10]  
CRUCIANI G, 2000, MODELING PREDICTION